7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel
| Autor: | John Staffurth, Robert Jones, T. Kheoh, Jinhui Li, Howard I. Scher, Karim Fizazi, Ana M. Molina, Christopher J. Logothetis, J.S. de Bono, C. M. Haqq |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Abiraterone acetate Phases of clinical research Castration resistant medicine.disease chemistry.chemical_compound Prostate cancer chemistry Docetaxel Prednisone Internal medicine medicine Overall survival In patient business medicine.drug |
| Zdroj: | European Journal of Cancer. 47:S483-S484 |
| ISSN: | 0959-8049 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect